Ying Ou

Also affiliated with Natus (United States), Technical Institute of Physics and Chemistry, National Center for Nanoscience and Technology, Hubei Engineering University, University of Chinese Academy of Sciences

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings”.

A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings

Frontiers in Immunology(2025)10.3389/fimmu.2024.1369619

N/A

0.343DataRank · unranked

7 citations

Camille N. Kotton, Jae‐Hyun Park, Giorgia Moranzoni, Camilla K. Lemvigh, Joseph Gathe +30 more